Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs MERCURY LAB. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH MERCURY LAB. PANACEA BIOTECH/
MERCURY LAB.
 
P/E (TTM) x -60.9 24.3 - View Chart
P/BV x 0.9 2.2 40.2% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 PANACEA BIOTECH   MERCURY LAB.
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
MERCURY LAB.
Mar-23
PANACEA BIOTECH/
MERCURY LAB.
5-Yr Chart
Click to enlarge
High Rs1911,000 19.1%   
Low Rs107390 27.5%   
Sales per share (Unadj.) Rs75.1627.8 12.0%  
Earnings per share (Unadj.) Rs-5.546.5 -11.9%  
Cash flow per share (Unadj.) Rs0.967.2 1.3%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs137.7380.2 36.2%  
Shares outstanding (eoy) m61.251.20 5,104.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.1 179.5%   
Avg P/E ratio x-27.114.9 -181.2%  
P/CF ratio (eoy) x170.010.3 1,643.2%  
Price / Book Value ratio x1.11.8 59.3%  
Dividend payout %07.5 -0.0%   
Avg Mkt Cap Rs m9,142834 1,096.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,265139 909.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,599753 610.5%  
Other income Rs m51717 3,005.4%   
Total revenues Rs m5,116771 664.0%   
Gross profit Rs m4786 54.6%  
Depreciation Rs m39125 1,575.6%   
Interest Rs m444 1,225.7%   
Profit before tax Rs m12875 170.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46619 2,432.1%   
Profit after tax Rs m-33756 -604.9%  
Gross profit margin %1.011.4 8.9%  
Effective tax rate %363.525.5 1,423.1%   
Net profit margin %-7.37.4 -99.1%  
BALANCE SHEET DATA
Current assets Rs m5,623417 1,348.2%   
Current liabilities Rs m3,297164 2,007.1%   
Net working cap to sales %50.633.6 150.7%  
Current ratio x1.72.5 67.2%  
Inventory Days Days597 822.1%  
Debtors Days Days481,035 4.6%  
Net fixed assets Rs m7,028259 2,717.2%   
Share capital Rs m6112 510.4%   
"Free" reserves Rs m8,375444 1,885.0%   
Net worth Rs m8,436456 1,848.8%   
Long term debt Rs m20224 832.9%   
Total assets Rs m12,712676 1,881.1%  
Interest coverage x3.921.7 17.9%   
Debt to equity ratio x00.1 45.0%  
Sales to assets ratio x0.41.1 32.5%   
Return on assets %-2.38.8 -26.2%  
Return on equity %-4.012.2 -32.7%  
Return on capital %2.016.3 12.2%  
Exports to sales %43.325.3 171.1%   
Imports to sales %24.40.4 6,944.8%   
Exports (fob) Rs m1,992191 1,044.3%   
Imports (cif) Rs m1,1243 42,401.1%   
Fx inflow Rs m1,992191 1,044.3%   
Fx outflow Rs m1,1918 15,074.4%   
Net fx Rs m801183 438.2%   
CASH FLOW
From Operations Rs m-4,22525 -17,228.9%  
From Investments Rs m4,303-11 -40,712.5%  
From Financial Activity Rs m-184-10 1,813.7%  
Net Cashflow Rs m-1054 -2,741.0%  

Share Holding

Indian Promoters % 73.6 73.7 99.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.0 -  
FIIs % 0.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 26.3 100.3%  
Shareholders   47,091 1,161 4,056.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs MERCURY LAB.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs MERCURY LAB. Share Price Performance

Period Panacea Biotech MERCURY LAB. S&P BSE HEALTHCARE
1-Day -1.74% -4.12% 1.18%
1-Month -20.01% -3.92% -0.75%
1-Year 11.75% 56.06% 61.82%
3-Year CAGR -12.26% 9.86% 18.16%
5-Year CAGR -9.98% 20.84% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the MERCURY LAB. share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of MERCURY LAB. the stake stands at 73.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of MERCURY LAB..

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

MERCURY LAB. paid Rs 3.5, and its dividend payout ratio stood at 7.5%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of MERCURY LAB..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.